Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Human Factors

Date Submitted: Jan 25, 2021
Date Accepted: Nov 27, 2021

The final, peer-reviewed published version of this preprint can be found here:

Implementation of E-prescription for Multidose Dispensed Drugs: Qualitative Study of General Practitioners’ Experiences

Knudsen Gullslett M, Bergmo T Sr

Implementation of E-prescription for Multidose Dispensed Drugs: Qualitative Study of General Practitioners’ Experiences

JMIR Hum Factors 2022;9(1):e27431

DOI: 10.2196/27431

PMID: 35037881

PMCID: 8804951

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

General Practitioners' experiences with introduction and use of e-prescribing for multidose dispensed drugs: A qualitative Study

  • Monika Knudsen Gullslett; 
  • Trine Bergmo Sr

ABSTRACT

Background:

Increased use of pharmaceuticals challenges both capacity and safety related to 1) medication management for patients and 2) changes in how General Practitioners and other health personnel interact with and follow-up of patients. E-prescribing of multidose dispensed drugs (eMDD) is one of the national measures that are being tested in Norway.

Objective:

The objective of this study was to reveal GPs´ experiences with the challenges and benefits of implementing eMDD in Norway.

Methods:

Qualitative in-depth interviews were conducted with a total of 25 GPs between 2018 and 2020. We used NVivo to conduct a step-by-step content analysis of audio files and transcribed text.

Results:

The study revealed that e-prescribing of MDD offers many benefits. At the same time, there are a number of challenges related to information, training and initiation, as well as to the responsibility for the medication, interactions and the risk of incorrect medication. An important activity in the start-up phase was an information meeting with pharmacies and technology suppliers, as well exchanging information and instructions with pharmacies on how to get started. The results are presented in four emergent analytic themes: 1) expectations, information and start-up with eMDD, 2) experiences with and need for training, 3) interaction—coordination of lists, security and efficiency, and 4) the working day with eMDD.

Conclusions:

There is a variety in different GPs needs regarding training and information and considerable variation in competence and motivation related to the use of digital tools. There were also different degrees of understanding concerning the everyday work of the other actors in the medication chain. Especially the harmonization of medication lists related to both use of time, expenditures and challenges with technological solutions the introduction phase was emphasized as a challenge.


 Citation

Please cite as:

Knudsen Gullslett M, Bergmo T Sr

Implementation of E-prescription for Multidose Dispensed Drugs: Qualitative Study of General Practitioners’ Experiences

JMIR Hum Factors 2022;9(1):e27431

DOI: 10.2196/27431

PMID: 35037881

PMCID: 8804951

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.